PCOS Laboratory Panel

The PCOS Laboratory Panel is a blood test panel used as part of the evaluation of hormonal patterns that may be associated with polycystic ovary syndrome. It includes estradiol, DHEA-S, follicle-stimulating hormone (FSH), luteinizing hormone (LH), total testosterone, free testosterone, sex hormone-binding globulin (SHBG), 17-hydroxyprogesterone, thyroid-stimulating hormone (TSH), and prolactin.

The panel brings together reproductive hormones, androgen-related markers, and tests that may help identify alternative explanations for symptoms that can resemble PCOS. It may be considered when menstrual cycles are irregular or absent, ovulation appears disrupted, pregnancy is difficult to achieve, or signs of androgen excess are present. These signs may include acne, hair loss, unwanted facial or body hair, and oily skin. Some patients also seek assessment because of weight gain and difficulty losing weight, although weight changes alone cannot establish a PCOS diagnosis.

What the PCOS Laboratory Panel measures

• Estradiol: provides information about estrogen activity and ovarian function within the context of the menstrual cycle.
• FSH and LH: are pituitary hormones involved in follicle development, ovulation, and menstrual cycle regulation.
• Total and free testosterone: help assess biochemical androgen excess. Free testosterone reflects the portion that is not tightly bound to carrier proteins.
• SHBG: binds sex hormones in the circulation and affects how much testosterone remains biologically available.
• DHEA-S: is an androgen produced mainly by the adrenal glands and can help clarify whether androgen excess may have an adrenal component.
• 17-hydroxyprogesterone: supports the assessment of conditions that may produce symptoms similar to PCOS, including nonclassic congenital adrenal hyperplasia.
• TSH: helps evaluate thyroid function because thyroid disorders can affect menstrual regularity, weight, energy, and fertility.
• Prolactin: is included because elevated prolactin can contribute to irregular or absent menstrual periods and impaired ovulation.

A blood panel cannot diagnose PCOS on its own

PCOS is not diagnosed from a single hormone value or from this laboratory panel alone. Diagnosis requires a broader clinical assessment that combines menstrual and ovulatory history, symptoms and clinical signs of androgen excess, biochemical hormone findings, and exclusion of other possible causes. A gynecological ultrasound may be used when it is needed to assess ovarian morphology or clarify the diagnostic picture.

In adults, the diagnostic process generally considers evidence of ovulatory dysfunction, clinical or biochemical hyperandrogenism, and polycystic ovarian morphology. The exact combination required depends on the clinical situation. When irregular cycles and clear hyperandrogenism are both present, an ultrasound may not always be necessary. In other cases, ultrasound or additional testing can provide important information. Assessment during adolescence requires particular caution because irregular cycles and acne can overlap with normal pubertal development.

Who may consider the panel

The panel may be useful for adults undergoing evaluation for irregular menstrual cycles, absent periods, suspected lack of ovulation, difficulty becoming pregnant, unwanted hair growth, scalp hair thinning, persistent acne, or other findings that raise concern about androgen excess. It may also form part of the evaluation when a clinician needs to distinguish PCOS from thyroid dysfunction, elevated prolactin, adrenal androgen excess, or another hormonal condition.

The panel is not intended as a stand-alone screening test for everyone with weight changes, acne, or hair loss. These symptoms have many possible causes. A clinician should interpret whether the panel is appropriate based on the patient’s age, menstrual history, symptoms, medications, hormonal contraception, pregnancy status, and previous findings.

Preparation and timing

Some hormone results can be influenced by the phase of the menstrual cycle, time of day, pregnancy, hormonal contraception, fertility treatment, and other medications. Before sampling, the patient should confirm whether the test needs to be performed on a particular cycle day or at a specified time.

Relevant information includes the first day of the last menstrual period, usual cycle length, whether cycles are regular, and whether hormonal medication is currently being used. Prescription medication, hormonal contraception, supplements, or fertility medication should not be stopped unless a treating clinician has specifically advised this.

Because prolactin can vary with stress, recent physical exertion, and the circumstances surrounding sampling, following the preparation instructions provided for the appointment helps improve result reliability. Any fasting requirement or additional preparation should be confirmed before the blood draw.

How the laboratory assessment works

Step 1: Review the clinical reason for testing

The reason for testing should be considered together with symptoms, menstrual history, previous hormone results, pregnancy plans, and current medication. This determines whether the panel is appropriate and whether additional tests may be needed.

Step 2: Confirm timing and preparation

Before the appointment, confirm the recommended cycle day, time of sampling, and any individual preparation instructions. Bring previous laboratory reports, ultrasound findings, and a current medication list when available.

Step 3: Blood sample collection

A blood sample is collected from a vein and used to measure all ten components included in the panel. The collection itself usually takes only a few minutes. Temporary discomfort, a small bruise, or lightheadedness can occasionally occur after sampling.

Step 4: Laboratory analysis

The sample is analyzed for reproductive hormones, androgens, hormone-binding proteins, thyroid regulation, prolactin, and 17-hydroxyprogesterone. The report presents the individual results with the applicable laboratory reference intervals.

Step 5: Clinical interpretation and next steps

The results should be interpreted together rather than as isolated abnormal or normal numbers. Depending on the findings, the next step may involve a gynecological or endocrinological assessment, gynecological ultrasound, fertility evaluation, or separate metabolic testing such as glucose and lipid assessment.

Understanding the results

A result outside the stated reference interval does not automatically confirm PCOS, and values within the reference interval do not necessarily exclude it. Hormone concentrations vary with age, cycle phase, laboratory method, medication, and individual physiology. Relationships between total testosterone, free testosterone, and SHBG may be particularly important when biochemical androgen excess is being assessed.

TSH, prolactin, and 17-hydroxyprogesterone help place androgen and reproductive hormone findings into a broader diagnostic context. Their inclusion can support the identification of conditions that may cause irregular cycles, ovulatory problems, or signs resembling PCOS. Further testing should be selected according to the clinical question rather than added automatically.

Practical next step through ZagrebMed

Before sending an inquiry, prepare a short description of cycle regularity, the date of the last menstrual period, current symptoms, pregnancy plans, medications, and any previous hormone or ultrasound findings. ZagrebMed can help clarify the practical next step and organize the appropriate laboratory or specialist pathway in Zagreb. The final diagnosis and interpretation should always be made by a qualified healthcare professional using the complete clinical picture.